Form 144 Twist Bioscience Corp For: 24 February
#Form 144 #Twist Bioscience #TWST #SEC filing #insider selling #biotechnology #DNA synthesis
📌 Key Takeaways
- Twist Bioscience filed Form 144 on February 24, 2026
- The filing indicates insiders may sell company shares
- TWST stock was down 1.03% at time of reporting
- The biotech company specializes in DNA synthesis and engineering
📖 Full Retelling
🏷️ Themes
SEC Filings, Biotechnology, Insider Trading
📚 Related People & Topics
TWST / Things We Said Today
2024 documentary film
TWST / Things We Said Today is a 2024 documentary film written and directed by Andrei Ujică. A co-production between France and Romania, it had its world premiere at the 81st edition of the Venice Film Festival.
DNA synthesis
Replication of DNA
DNA synthesis is the natural or artificial creation of deoxyribonucleic acid (DNA) molecules. DNA is a macromolecule made up of nucleotide units, which are linked by covalent bonds and hydrogen bonds, in a repeating structure. DNA synthesis occurs when these nucleotide units are joined to form DNA; ...
SEC filing
Type of financial statements in the United States
# SEC Filing An **SEC filing** is a formal financial statement or regulatory document submitted to the **U.S. Securities and Exchange Commission (SEC)**. These filings are mandatory requirements designed to ensure transparency, providing a standardized method for disclosing material information to ...
Twist Bioscience
American Biotechnology company
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 20...
Entity Intersection Graph
No entity connections available yet for this article.
Deep Analysis
Why It Matters
A Form 144 filing indicates that corporate insiders or major shareholders plan to sell a significant amount of stock, which can signal their confidence in the company's future prospects and impact the stock price. This filing for Twist Bioscience Corp is important for investors monitoring potential changes in ownership and market sentiment.
Context & Background
- Form 144 is an SEC filing required when insiders intend to sell restricted or control securities
- Twist Bioscience Corp (TWST) is a company that provides synthetic DNA and genomics solutions
- The stock price of TWST decreased by 1.03% on the day of the filing
What Happens Next
The filing will be processed by the SEC, and the insider will likely proceed with the planned sale of shares if all conditions are met. Market participants will monitor the transaction's execution and its potential effect on Twist Bioscience's stock liquidity and price.
Frequently Asked Questions
A Form 144 is a notice of proposed sale of securities filed with the SEC by corporate insiders or affiliates who plan to sell restricted or control shares.
Form 144 is typically filed by officers, directors, or major shareholders (affiliates) of a company who intend to sell company stock.
It can indicate potential selling pressure if a large volume of shares is to be sold, which may influence the stock price and investor perception.